Pulmonary Fibrosis: all 685 studies

Page 7 of 7. Open to participants first (120), then studies with results posted, then the rest; newest registration first within each.

• Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01462006Not applicable
• IPF Drug Deposition StudyCompletedNCT01457261Phase 1
• Clinical and Pathophysiological Investigations Into Erdheim Chester DiseaseCompletedNCT01417520
• Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy PatientsStatus unknownNCT01382368Phase 4
• A Study to Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary FibrosisCompletedNCT01362231Phase 1
• Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary FibrosisWithdrawnNCT01346930Phase 2
• 68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary FibrosisTerminatedNCT01321996Phase 4
• Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant RecipientsCompletedNCT01289717
• Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU StudyCompletedNCT01271842
• Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT01266135Phase 2
• Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.CompletedNCT01265888Phase 2
• Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary FibrosisCompletedNCT01262001Phase 2
• Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant SuitabilityTerminatedNCT01241942Not applicable
• A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT01203943Phase 2
• Pharmacokinetic Study of Extended Infusion Meropenem in Adult Cystic Fibrosis PatientsTerminatedNCT01158937Not applicable
• Case-Control Study of Fibrotic Interstitial Lung Disease (ILD) and Cardiac Disease / Interventions.Status unknownNCT01154998
• Peripheral Blood Biomarkers in Idiopathic Interstitial PneumoniasTerminatedNCT01151527
• Microaspiration in Pulmonary FibrosisCompletedNCT01150591
• Pomalidomide for Cough in Patients With Idiopathic Pulmonary FibrosisWithdrawnNCT01135199Phase 2
• Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England)CompletedNCT01134822
• Study on Phenotypic Characterization of Combined Pulmonary Fibrosis and EmphysemaCompletedNCT01121367
• Molecular Phenotypes for Cystic Fibrosis Lung DiseaseCompletedNCT01116414
• Prospective Observation of Fibrosis in the Lung Clinical Endpoints StudyCompletedNCT01110694
• Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary FibrosisCompletedNCT01107028
• Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01071707
• Written Disclosure Therapy for Anxiety and Stress in Patients With Chronic Lung DiseaseCompletedNCT00911794Not applicable
• Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer PatientsStatus unknownNCT00896155Phase 3
• Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung CancerWithdrawnNCT00880386Not applicable
• Idiopathic Pulmonary Fibrosis Registry for Future StudiesCompletedNCT00815711
• A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00786201Phase 2
• Pulmonary Rehabilitation for Idiopathic Pulmonary FibrosisCompletedNCT00692796Not applicable
• Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary FibrosisTerminatedNCT00690885Phase 2
• Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00639496Phase 3
• Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment StudyStatus unknownNCT00637065Phase 4
• Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With BosentanWithdrawnNCT00625469Phase 4
• Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With SildenafilWithdrawnNCT00625079Phase 4
• Dyspnea in Patients With Pulmonary FibrosisCompletedNCT00611182
• QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic SclerosisTerminatedNCT00581997Phase 2
• A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary FibrosisCompletedNCT00563212Phase 1
• Pennsylvania Idiopathic Pulmonary Fibrosis Research RegistryCompletedNCT00540475
• SD, IL-13 Production Rate in IPFCompletedNCT00532233Phase 2
• Azathioprine and Prednisone in the Treatment of Idiopathic Pulmonary FibrosisStatus unknownNCT00518310Not applicable
• The Occurence of Inflammation and Oxidative Stress in Lung DiseasesCompletedNCT00512967
• The Influence of Personality on Pulmonary Fibrosis and SarcoidosisCompletedNCT00504621
• Treatment of Idiopathic Pulmonary Fibrosis with Long Acting OctreotideCompletedNCT00463983Phase 1/2
• Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) PatientsCompletedNCT00455767Phase 2
• Race, Ethnicity, and Diffuse Parenchymal Lung DiseaseCompletedNCT00453713
• Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary FibrosisStatus unknownNCT00439543Phase 2/3
• Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung DiseaseTerminatedNCT00425165Phase 2
• Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System DiseasesCompletedNCT00366509
• Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung DiseaseCompletedNCT00357279Phase 3
• Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary HypertensionCompletedNCT00352482Phase 2
• Zileuton for the Treatment of Idiopathic Pulmonary FibrosisCompletedNCT00262405Phase 2
• Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)Active, not recruitingNCT00258544
• Herpesvirus in Idiopathic Pulmonary FibrosisCompletedNCT00228670
• Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF RegistryWithdrawnNCT00212511
• Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot StudyStatus unknownNCT00203697Phase 3
• Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary FibrosisCompletedNCT00189176Phase 1/2
• Treatment of Idiopathic Pulmonary Fibrosis With ThalidomideCompletedNCT00162760Phase 2
• Gleevec Idiopathic Pulmonary Fibrosis (IPF) StudyCompletedNCT00131274Phase 2/3
• A Study in Pediatric Patients With Cystic Fibrosis Lung DiseaseCompletedNCT00130182Phase 2
• Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary RehabilitationStatus unknownNCT00129350Phase 1
• Study of GC1008 in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00125385Phase 1
• Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary FibrosisCompletedNCT00109681Phase 2
• Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung DiseaseCompletedNCT00103714Phase 2
• Analysis of Specimens From Individuals With Pulmonary FibrosisActive, not recruitingNCT00084305
• An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPFTerminatedNCT00076635Phase 3
• The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT00075998Phase 3
• Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary FibrosisCompletedNCT00074698Phase 1
• Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary FibrosisCompletedNCT00071461Phase 2/3
• Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With SclerodermaCompletedNCT00070590Phase 2/3
• Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary FibrosisCompletedNCT00063869Phase 2
• Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung DiseaseCompletedNCT00056147Phase 2
• An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00052052Phase 2
• A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving PrednisoneTerminatedNCT00052039Phase 3
• A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00047658Phase 2
• A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00047645Phase 3
• Linkage Study in Familial Pulmonary FibrosisCompletedNCT00016627
• Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung DiseasesCompletedNCT00005317
• Idiopathic Pulmonary Fibrosis: a Case-control StudyTerminatedNCT00005295
• Identification of Genes Associated With Lung Disease in Patients With Rheumatoid ArthritisCompletedNCT00001885
• Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid ArthritisCompletedNCT00001884
• Lung Disease Associated With Rheumatoid ArthritisCompletedNCT00001876
• Segmental Bronchoalveolar LavageCompletedNCT00001618
• Diffuse Fibrotic Lung DiseaseCompletedNCT00000596Phase 2

← Pulmonary Fibrosis overview